Find clinical trials for Non-Small-Cell Lung Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near New York, NY, USA:
body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung cancer (NSCLC) t...
Phase 2
New York, New York, United States and 8 other locations
This is a phase 3, open-label, 4-cohort study (3 randomized cohorts and 1 single-arm cohort). Participants enrolled in each cohort will be treated as...
Phase 3
East Brunswick, New Jersey, United States and 30 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
New York, New York, United States and 84 other locations
3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous NSCL...
Phase 1
New York, New York, United States and 36 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
New York, New York, United States and 83 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
New York, New York, United States and 124 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
The Bronx, New York, United States and 210 other locations
is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung Cancer (NSCLC). This...
Phase 1
New York, New York, United States and 26 other locations
with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) wi...
Phase 2
New York, New York, United States and 61 other locations
HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...
Phase 1
New York, New York, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal